Invited Speakers

Prof. Dr. Ale Algra

University Medical Center Utrecht, The Netherlands

JUNE 27, 2019 08:30 - 10:15
Risk factors for and time trends in the worldwide incidence of aneurysmal subarachnoid hemorrhage


view bio

Prof. Dr. Sepideh Amin-Hanjani

University of Illinois, USA

JUNE 26, 2019 16:30 - 18:00
Advances/challenges in aneurysm repair (a neurosurgical perspective)


view bio

Prof. Dr. Tomohiro Aoki

Kyoto University, Japan

JUNE 26, 2019 11:00 - 12:45
Molecular basis for aneurysm wall formation, growth and rupture.


view bio

Associate Professor Alex H. Choi

University of Texas, USA

JUNE 26, 2019  08:45 - 10:30
Role of inflammation in early brain injury after SAH


view bio

Associate Professor Sherry Hsiang-Yi Chou

University of Pittsburgh, USA

JUNE 26, 2019 16:30 - 18:00
Established and promising biomarkers in SAH


view bio

Associate Professor Jan Claassen

Columbia University, USA

JUNE 28, 2019 08:30 - 10:30
Electrophysiological monitoring after aneurysmal SAH


view bio

Prof. Dr. Michael Diringer

Washington University, USA

JUNE 27, 2019 14:00 - 15:45
Subarachnoid hemorrhage is a multisystem disease


view bio

Prof. Dr. Jens Dreier

Charité University Berlin, Germany

JUNE 26, 2019 14:15 - 16:00
20 years of research on cortical spreading depolarizations: answered and unanswered questions


view bio

Assistant Professor Shane English

The Ottawa Hospital, Canada

JUNE 27, 2019  10:45 - 12:30
Aneurysmal subarachnoid hemorrhage - red blood cell transfusion and outcome (SAHaRA): a randomized controlled trial (rationale and study status).


view bio

Prof. Dr. Nima Etminan

Medical Faculty Mannheim, University of Heidelberg, Germany

JUNE 27, 2019  10:45 - 12:30
PROTECT-U (rationale and study status)


view bio

Assistant Professor Thomas Gaberel

University Hospital of Caen, France

JUNE 27, 2019  10:45 - 12:30
French Intraventricular fibrinolysis trial (rationale and study status)


view bio

Prof. Dr. Daniel Hänggi

University of Heidelberg, Germany, Medical Faculty Mannheim

JUNE 27, 2019  10:45 - 12:30
Final results of the NEWTON 2 trial


view bio

Associate Professor David Hasan

University of Iowa Hospitals, USA

JUNE 27, 2019  16:15 - 18:00
Novel radiological surrogates to estimate the risk of rupture in intracranial aneurysms


view bio

Associate Professor Raimund Helbok

Medical University of Innsbruck, Austria

JUNE 27, 2019 14:00 - 15:45
Respiratory complications and management in patients with SAH


view bio

Prof. Dr. Nerissa Ko

University of California, San Francisco, USA

JUNE 27, 2019 10:45 - 12:30
Defining and monitoring neuroinflammation in SAH


view bio

Prof. Dr. Martin Lauritzen

University of Copenhagen, Denmark

JUNE 27, 2019  08:30 - 10:15
Neurovascular coupling and CBF regulation in the healthy brain


view bio

Associate Professor Hester Lingsma

Erasmus MC, The Netherlands

JUNE 28, 2019  11:00 - 12:45
Alternative study designs for studying the effect of interventions in patients with SAH – pros and cons

Prof. Dr. Robert Loch Macdonald

Edge Therapeutics, Inc. / University of Toronto, Canada

JUNE 26, 2019  08:45 - 10:30
Relationship between early brain injury and delayed cerebral ischemia


view bio

PD Dr. Med. Serge Marbacher

Kantonsspital Aarau, Switzerland

JUNE 27, 2019  08:30 - 10:15
Animal models in SAH research: towards standardization of experiments.


view bio

Prof. Dr. Stephan A. Mayer

William T. Gossett Endowed Chair of Neurology, USA

Neuropsychological outcomes in SAH patients: lessons learned and future perspectives


view bio

Prof. Dr. Akio Morita

Nippon Medical School, Japan

JUNE 26, 2019 11:00 - 12:45
Lessons learned from a ‘natural history study’ in unruptured intracranial aneurysms


view bio

Assistant Professor Sarah Nelson

Johns Hopkins Hospital, USA

JUNE 27, 2019  16:15 - 18:00
Quantifying MRI-specific features of injury in SAH


view bio

Prof. Dr. Hiroki Ohkuma

University of Hirosaki, Japan

JUNE 28, 2019 08:30 - 10:30
Microthrombosis and arteriolar constrictions after SAH


view bio

MD Hiren Patel

University of Manchester, UK

JUNE 27, 2019  10:45 - 12:30
Interleukin-1 receptor antibodies for SAH (rationale and study status)


view bio

Prof. Dr. Nikolaus Plesnila

Ludwig- Maximilians Universitat München, Germany

JUNE 27, 2019  08:30 - 10:15
Translation of animal research into novel clinical treatments


view bio

Associate Professor Javier Provencio

University of Virginia School of Medicine, USA

JUNE 28, 2019 08:30 - 10:30
Brain monitoring after SAH: lessons learned


view bio

Prof. Dr. Gabriel Rinkel

University Medical Center Utrecht, The Netherlands

JUNE 27, 2019 08:30 - 10:15
Long-term outcomes after SAH


view bio

Associate Professor Ynte Ruigrok

University Medical Center Utrecht, The Netherlands

JUNE 26, 2019 16:30 - 18:00
The International Stroke Genetics Consortium; how it will improve our knowledge on the role of genetics in patients with intracranial aneurysms


view bio

Associate Professor Gerrit Alexander Schubert

RWTH Aachen University

JUNE 26, 2019 11:00 - 12:45
Neurovascular coupling and cerebral blood flow in SAH patients


view bio

Prof. Dr. Bill Shuttleworth

University of New Mexico, USA

JUNE 28, 2019 08:30 - 10:30
Relationship between spreading depolarizations and microcirculatory disturbances after SAH


view bio

Prof. Dr. Jose Suarez

Johns Hopkins Hospital, USA

JUNE 28, 2019  11:00 - 12:45
ALISAH II / summary update and the future of Common Data Elements in SAH research


view bio

Prof. Dr. Hidenori Suzuki

Mie University, Japan

JUNE 27, 2019 10:45 - 12:30
Neuroinflammation as a target for intervention in subarachnoid hemorrhage


view bio

Assistant Professor Walter van den Bergh

University of Groningen, The Netherlands

JUNE 26, 2019 14:15 - 16:00
Is there a role for hypertension induction after the HIMALAIA trial?


view bio

Prof. Dr. Peter Vandertop

Amsterdam University Medical Centers , The Netherlands

JUNE 27, 2019  10:45 - 12:30
ULTRA early tranexamic acid after subarachnoid hemorrhage (rationale and study status)


view bio

Associate Professor Mervyn Vergouwen

University Medical Center Utrecht, The Netherlands

JUNE 27, 2019  10:45 - 12:30
PROTECT-U (rationale and study status)


view bio

Dr. Stefan Wolf

Charité University Berlin, Germany

JUNE 27, 2019  10:45 - 12:30
EARLY DRAIN trial (rational and study status)


view bio

Prof. Dr. Kwok Chu George Wong

Chinese University of Hong Kong, China

JUNE 27, 2019 16:15 - 18:00
Cerebral infarction and cognitive outcome after SAH


view bio

Newsletter

Sign up to be notified of news

Venue

Muziekgebouw aan 't IJ Amsterdam
Piet Heinkade 1
1019 BR Amsterdam, The Netherlands
Founded in 2005; Muziekgebouw aan 't IJ is the most important stage for contemporary music in the Netherlands. It is located above the IJtunnel, a ten-minute walk from Amsterdam Central Station. The building was designed by Danish architects 3XN. Spacious modern rooms, parking directly under the building and an unparalleled view: Muziekgebouw aan 't IJ has it all in house.

Organization Secretariat

Kenes M+

General Inquiries:
Ms. Merve Tufekci
mtufekci@kenes.com